Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study (Q51872146)

14 April 2018

title

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study (English)

1 reference

14 April 2018

0 references

1 reference

1 reference

1 reference

14 April 2018

Robert Perneczky

1 reference

14 April 2018

Johannes Kornhuber

1 reference

14 April 2018

Jens Wiltfang

1 reference

14 April 2018

J Popp

0 references

P Lewczuk

1 reference

14 April 2018

Lutz Frölich

object named as

L Frölich

1 reference

14 April 2018

author name string

H Kamrowski-Kruck

1 reference

14 April 2018

O Peters

1 reference

14 April 2018

I Heuser

1 reference

14 April 2018

F Jessen

1 reference

14 April 2018

K Bürger

1 reference

14 April 2018

H Hampel

1 reference

14 April 2018

S Wolf

1 reference

14 April 2018

B Prinz

1 reference

14 April 2018

Ch Luckhaus

1 reference

14 April 2018

M Hüll

1 reference

14 April 2018

J Schröder

1 reference

14 April 2018

H Kessler

1 reference

14 April 2018

J Pantel

1 reference

14 April 2018

H-J Gertz

1 reference

14 April 2018

H-W Klafki

1 reference

14 April 2018

H Kölsch

1 reference

14 April 2018

U Reulbach

1 reference

14 April 2018

H Esselmann

1 reference

14 April 2018

J M Maler

1 reference

14 April 2018

M Bibl

1 reference

14 April 2018

language of work or name

English

0 references

publication date

29 July 2008

1 reference

14 April 2018

published in

Molecular Psychiatry

1 reference

14 April 2018

volume

1 reference

14 April 2018

issue

1 reference

14 April 2018

page(s)

138-145

1 reference

14 April 2018

Evaluation and use of diagnostic tests in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Therapeutic approaches to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Disease-modifying therapies in Alzheimer's disease: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Neurochemical dementia diagnostics: State of the art and research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

The Bayer Activities of Daily Living Scale (B-ADL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Splice variants of the beta-site APP-cleaving enzyme BACE1 in human brain and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Electrophoretic separation of amyloid beta peptides in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Cerebrospinal fluid markers for prediction of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

7 January 2021

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

7 January 2021

Severity of family distress of schizophrenia--fact or artifact?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

7 January 2021

A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.84

7 January 2021

Identifiers

DOI

10.1038/MP.2008.84

1 reference

14 April 2018

1 reference

14 April 2018